Sen. Josh Hawley to Google over pro-life censorship: Stop the anti-life bias

Google, Josh Hawley, censorship

On September 15, U.S. Senator Josh Hawley (R-Mo.) sent a letter to Google CEO Sundar Pichai demanding answers for the tech giant’s censorship of pro-life ads. According to a press release, Hawley’s letter specifically referenced Google’s recent removal of Live Action’s abortion pill reversal ads, citing alleged ‘unreliable claims’ and ‘misleading content.’ Hawley also mentioned Google’s removal of pregnancy care center ads by Choose Life Marketing, a pro-life marketing organization based out of his home state.

In the letter, Hawley wrote, “When I spoke with Mark Zuckerberg about a similar issue in September 2019, he acknowledged the danger of bias on the parts of content reviewers in this area, particularly where pro-life activist groups like Live Action are concerned.” The letter continued, “But if your company’s behavior is any indication, those concerns have gone unaddressed. Rather, your company appears to have taken a page out of the progressive left playbook and has started targeting pregnancy resource centers and pro-life activist organizations for disfavor.”

“This would not be the first time that political considerations have influenced your company’s ad eligibility decisions,” Hawley pointedly observed.

READ: Senators demand answers from Google following Live Action censorship

Hawley listed multiple action item questions for Pichai to address. Among them:

  • Why were Live Action’s advertising campaigns abruptly disapproved by Google?
  • At what rate are ads produced by crisis pregnancy centers, pro-life advocacy organizations, and firms that work with them, deemed ineligible for distribution on Google’s platform?
  • What contacts have Google executives or other leaders had with abortion advocacy organizations in the last month?
  • It has been widely reported that a number of aggressive internal cadres of progressive employees are active within Google, leading to harsh backlash against employees who do not share these views. What steps has Google taken to ensure that ad eligibility decisions are not affected by employee bias?

Fox Business article about the letter noted that a Google representative said one of the 18 blocked Live Action ads had been restored upon review. The representative insisted that the abortion pill reversal ads remained down because of the claims of “medical experts” — failing to note that these experts promote abortion and many monetarily profit directly from abortion:

We do not permit ads with unproven medical claims. Medical experts have raised serious concerns about abortion reversal pills. Beyond protecting users from medical harm, our policies do not distinguish between promoting pro-choice and pro-life messages. Advertisers are allowed to offer either abortion or abortion-alternative services. When doing so, both must prominently disclose which type of service they offer so that users have full transparency and can make their own decisions.

This “transparency” policy change was instituted in 2019 following — once again — complaints from abortion profiteers and their media friends.

A September 14 Live Action press release directly countered Google’s statements concerning abortion pill reversal, noting that Google “has obviously failed to understand the FDA-approved treatment that [abortion pill] reversal technology uses. Live Action and pro-life medical professionals across the country are proud to promote the Abortion Pill Reversal regimen, which involves an FDA-approved, bio-identical pregnancy hormone called progesterone that has been used for dozens of years to prevent miscarriage and has already saved thousands of lives.”

Rose discussed Google’s apparent double standard when it comes to abortion pill ads versus abortion pill reversal ads, telling Fox News, “It’s extreme and unprecedented bias in support of the abortion industry. They are currently allowing promotions for abortion pills, which force miscarriage, which end pregnancies and kill children, and they refuse to allow an FDA-approved treatment to be promoted to the women who want it.”

“Like” Live Action News on Facebook for more pro-life news and commentary!

What is Live Action News?

Live Action News is pro-life news and commentary from a pro-life perspective. Learn More

Contact for questions, corrections, or if you are seeking permission to reprint any Live Action News content.

GUEST ARTICLES: To submit a guest article to Live Action News, email with an attached Word document of 800-1000 words. Please also attach any photos relevant to your submission if applicable. If your submission is accepted for publication, you will be notified within three weeks. Guest articles are not compensated. (See here for Open License Agreement.) Thank you for your interest in Live Action News!

To Top